[INFLUENCE OF DRUGS WITH PROTECTIVE ACTION ON THE LEUKOPENIC EFFECT FOLLOWING THE CHEMIO-RADIOTHERAPEUTIC ASSOCIATION].
D001205:Ascorbic Acid; D003520:Cyclophosphamide; D007857:Leadership; D007960:Leukocyte Disorders; D007970:Leukopenia; D009113:Muramidase; D009369:Neoplasms / Q000532:radiotherapy*; D011422:Propionates; D011837:Radiation-Protective Agents; D013739:Testosterone; D014116:Toxicology
D011422:Propionates; D011837:Radiation-Protective Agents; D013739:Testosterone; D003520:Cyclophosphamide; D009113:Muramidase; D001205:Ascorbic Acid
ASCORBIC ACID; CYCLOPHOSPHAMIDE; LEUKOPENIA; MURAMIDASE; NEOPLASM RADIOTHERAPY; PROPIONATES; RADIATION-PROTECTIVE AGENTS; TESTOSTERONE; TOXICOLOGIC REPORT
INFLUENZA DI FARMACI AD AZIONE PROTETTIVA SULL'EFFETTO LEUCOPENICO CONSEGUENTE ALL'ASSOCIAZIONE CHEMIO-RADIOTERAPICA.